Search
Beta Bionics Inc
BBNXAdd to Watchlist
16.950USD
+1.250+7.96%
Close 11-09 16:00（ET）
921.57MMarket Cap
LossP/E TTM
Beta Bionics Inc (BBNX) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Beta Bionics Inc in the past month.
Buy
4 Strong Buy
5 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
25.100USD+49.85%
BBNX Analyst Recommendation Trends
In the current month, BBNX has received 5 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. BBNX average Analyst price target in the last month is 25.100.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
4
4
4
4
5
5
4
5
5
5
5
5
4
4
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
11
12
12
12
12
12
BBNX Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, BBNX EPS is projected to reach -0.555 in FY2026Q4, following reported EPS of -0.523 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.49
-0.60
-0.55
-0.56
-0.55
Actual
-0.49
-0.53
-0.52
--
--
Surprise
-0.85%
+11.80%
+4.86%
--
--
FAQs
What is Beta Bionics Inc's expected revenue for the next quarter?
Beta Bionics Inc's expected revenue is 30.50M.
What is Beta Bionics Inc's price target?
Analysts forecast that Beta Bionics Inc's price target is USD 25.10, with the highest forecast at USD 30.40 and the lowest forecast at USD 16.00.
How have Beta Bionics IncBBNX's recent earnings per share performed?
The market expectation was USD -0.52, while Beta Bionics IncBBNX's earnings per share (EPS) for the previous quarter was USD -0.53. EPS for the next quarter is expected at USD -0.56.
What is the analyst rating for Beta Bionics Inc?
Based on the ratings of Beta Bionics Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.